Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ · Healthcare
Rigel Pharmaceuticals, Inc. Revenue 2016–2025
Rigel Pharmaceuticals, Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Rigel Pharmaceuticals, Inc. revenue for the quarter ending March 31, 2026 was 58.8 M, a 10.28% increase year-over-year.
- Rigel Pharmaceuticals, Inc. revenue for the twelve months ending March 31, 2026 was 283.3 M, a 89.10% increase year-over-year.
- Rigel Pharmaceuticals, Inc. annual revenue for 2025 was 294.3 M, a 64.15% increase from 2024.
- Rigel Pharmaceuticals, Inc. annual revenue for 2024 was 179.3 M, a 53.38% increase from 2023.
- Rigel Pharmaceuticals, Inc. annual revenue for 2023 was 116.9 M, a 2.79% decrease from 2022.
- Rigel Pharmaceuticals, Inc. annual revenue for 2022 was 120.2 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Rigel Pharmaceuticals, Inc. Market Cap — FAQ
Rigel Pharmaceuticals, Inc. (RIGL) market cap over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RIGL's market cap history?
The chart and table above show Rigel Pharmaceuticals, Inc.'s market cap by year and by quarter, including the growth rate.